TROG 10.02 - RAPID - TROG Cancer Research

By w.paterson
23 June, 2021
0 Comments

Randomized trial of accelerated partial breast irradiation

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

1 October, 2024

A plan for the future of cancer research

12 September 2024: TROG Cancer Research has outlined how

TOPGEAR trial results published in the New England Journal of Medicine

18 September, 2024

TOPGEAR trial findings published in NEJM

18 September 2024: We’re thrilled to announce the release

Join us to raise $20,000

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

Randomized trial of accelerated partial breast irradiation

TROG 11.02 – SCORAD III

TROG 10.01 – BOLART

Related Post

A plan for the future of cancer research

TOPGEAR trial findings published in NEJM

Join us to raise $20,000

TROG 10.02 – RAPID

Randomized trial of accelerated partial breast irradiation

TROG 11.02 – SCORAD III

TROG 10.01 – BOLART

Related Post

A plan for the future of cancer research

TOPGEAR trial findings published in NEJM

Join us to raise $20,000